Latest News and Press Releases
Want to stay updated on the latest news?
-
PharmAla completes historic first shipment of MDMA from Canada to USA for use in a UCLA Clinical Trial
-
The first-ever dedicated podcast recording area at a Psychedelic Science conference offers podcasters a prime location to capture conversations with scientists, policymakers, and industry leaders...
-
MAPS’ next Executive Director will be a bold movement leader and visionary responsible for implementing MAPS' new strategic impact plan, ensuring programmatic excellence, advancing global expansion,...
-
PharmAla adds Matthew Azrieli to Advisory Team
-
PharmAla releases its Q1 financial statements
-
PharmAla files audited financials for year ended August 31, 2024, completes continuance and oversubscribed private placement
-
PharmAla announces private placement financing
-
World’s leading psychedelic conference kicks off with workshops from leaders in science, medicine, therapy, policy, Indigenous medicine, and societyUpcoming deadline: speaker submissions, initial...
-
PharmAla reaches agreement in principle to trade with a clinical trial to trade its LaNeo MDMA for a data license to the trial outcomes.
-
PharmAla to supply Yale University with MDMA for clinical trial